# Saul Centers, Inc.: financial statements, quarterly

BFS · NYSE · CIK 907254 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bfs.md) · [Financials](/companies/bfs/financials.md) · [Filings](/companies/bfs/filings.md) · [Insiders](/companies/bfs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bfs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [63.8](/filings/0000907254-24-000100.md) | [66.7 d](/filings/0000907254-26-000006.md) | [66.7](/filings/0000907254-25-000047.md) | [66.9](/filings/0000907254-25-000102.md) | [67.3](/filings/0000907254-25-000108.md) | [67.9 d](/filings/0000907254-26-000006.md) | [71.9](/filings/0000907254-26-000032.md) | [70.8](/filings/0000907254-26-000049.md) | [72.0](/filings/0000907254-25-000108.md) | [75.1 d](/filings/0000907254-26-000006.md) | [78.3](/filings/0000907254-26-000032.md) | [76.8](/filings/0000907254-26-000049.md) |
| Cost of revenue | $m | [17.4](/filings/0000907254-24-000100.md) | [17.0 d](/filings/0000907254-24-000020.md) | [18.2](/filings/0000907254-24-000042.md) | [17.3](/filings/0000907254-24-000088.md) | [17.7](/filings/0000907254-24-000100.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [46.4](/filings/0000907254-24-000100.md) | [49.6 d](/filings/0000907254-24-000020.md) | [48.5](/filings/0000907254-24-000042.md) | [49.7](/filings/0000907254-24-000088.md) | [49.6](/filings/0000907254-24-000100.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | [48.3](/filings/0000907254-25-000047.md) | [50.2](/filings/0000907254-25-000102.md) | [49.0](/filings/0000907254-25-000108.md) | [56.3 d](/filings/0000907254-26-000006.md) | [47.8](/filings/0000907254-26-000032.md) | [48.7](/filings/0000907254-26-000049.md) | [49.8](/filings/0000907254-25-000108.md) | [49.1 d](/filings/0000907254-26-000006.md) | [51.6](/filings/0000907254-26-000032.md) | [52.0](/filings/0000907254-26-000049.md) |
| Interest expense | $m | [12.5](/filings/0000907254-24-000100.md) | [12.7 d](/filings/0000907254-26-000006.md) | [12.5](/filings/0000907254-25-000047.md) | [12.3](/filings/0000907254-25-000102.md) | [12.3](/filings/0000907254-25-000108.md) | [16.8 d](/filings/0000907254-26-000006.md) | [16.8](/filings/0000907254-26-000032.md) | [16.9](/filings/0000907254-26-000049.md) | [17.1](/filings/0000907254-25-000108.md) | [20.0 d](/filings/0000907254-26-000006.md) | [19.7](/filings/0000907254-26-000032.md) | [20.1](/filings/0000907254-26-000049.md) |
| Net income | $m | [12.8](/filings/0000907254-24-000100.md) | [13.2 d](/filings/0000907254-26-000006.md) | [13.6](/filings/0000907254-25-000047.md) | [14.4](/filings/0000907254-25-000102.md) | [14.5](/filings/0000907254-25-000108.md) | [8.1 d](/filings/0000907254-26-000006.md) | [9.8](/filings/0000907254-26-000032.md) | [10.7](/filings/0000907254-26-000049.md) | [10.5](/filings/0000907254-25-000108.md) | [6.5 d](/filings/0000907254-26-000006.md) | [9.1](/filings/0000907254-26-000032.md) | [8.8](/filings/0000907254-26-000049.md) |
| Diluted EPS | $ per share | [0.42](/filings/0000907254-24-000100.md) | not reported | [0.45](/filings/0000907254-25-000047.md) | [0.48](/filings/0000907254-25-000102.md) | [0.48](/filings/0000907254-25-000108.md) | not reported | [0.29](/filings/0000907254-26-000032.md) | [0.33](/filings/0000907254-26-000049.md) | [0.32](/filings/0000907254-25-000108.md) | not reported | [0.26](/filings/0000907254-26-000032.md) | [0.24](/filings/0000907254-26-000049.md) |
| Basic EPS | $ per share | [0.42](/filings/0000907254-24-000100.md) | not reported | [0.45](/filings/0000907254-25-000047.md) | [0.48](/filings/0000907254-25-000102.md) | [0.48](/filings/0000907254-25-000108.md) | not reported | [0.29](/filings/0000907254-26-000032.md) | [0.33](/filings/0000907254-26-000049.md) | [0.32](/filings/0000907254-25-000108.md) | not reported | [0.26](/filings/0000907254-26-000032.md) | [0.24](/filings/0000907254-26-000049.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.6](/filings/0000907254-23-000097.md) | [8.4](/filings/0000907254-25-000022.md) | [7.1](/filings/0000907254-24-000042.md) | [6.9](/filings/0000907254-24-000088.md) | [7.2](/filings/0000907254-24-000100.md) | [10.3](/filings/0000907254-26-000006.md) | [6.5](/filings/0000907254-25-000047.md) | [5.3](/filings/0000907254-25-000102.md) | [11.8](/filings/0000907254-25-000108.md) | [8.7](/filings/0000907254-26-000049.md) | [9.3](/filings/0000907254-26-000032.md) | [5.9](/filings/0000907254-26-000049.md) |
| Total assets | $m | [1,961](/filings/0000907254-24-000100.md) | [1,994](/filings/0000907254-26-000006.md) | [2,030](/filings/0000907254-25-000047.md) | [2,072](/filings/0000907254-25-000102.md) | [2,113](/filings/0000907254-25-000108.md) | [2,126](/filings/0000907254-26-000006.md) | [2,131](/filings/0000907254-26-000032.md) | [2,140](/filings/0000907254-26-000049.md) | [2,168](/filings/0000907254-25-000108.md) | [2,163](/filings/0000907254-26-000049.md) | [2,157](/filings/0000907254-26-000032.md) | [2,159](/filings/0000907254-26-000049.md) |
| Total liabilities | $m | [1,450](/filings/0000907254-23-000097.md) | [1,490](/filings/0000907254-25-000022.md) | [1,516](/filings/0000907254-24-000042.md) | [1,559](/filings/0000907254-24-000088.md) | [1,604](/filings/0000907254-24-000100.md) | [1,625](/filings/0000907254-26-000006.md) | [1,640](/filings/0000907254-25-000047.md) | [1,651](/filings/0000907254-25-000102.md) | [1,682](/filings/0000907254-25-000108.md) | [1,685](/filings/0000907254-26-000049.md) | [1,683](/filings/0000907254-26-000032.md) | [1,690](/filings/0000907254-26-000049.md) |
| Long-term debt | $m | [1,343](/filings/0000907254-23-000097.md) | [332](/filings/0000907254-24-000020.md) | [1,409](/filings/0000907254-24-000042.md) | [1,443](/filings/0000907254-24-000088.md) | [1,493](/filings/0000907254-24-000100.md) | [456](/filings/0000907254-25-000022.md) | [1,545](/filings/0000907254-25-000047.md) | [1,565](/filings/0000907254-25-000102.md) | [1,588](/filings/0000907254-25-000108.md) | [468](/filings/0000907254-26-000006.md) | [1,598](/filings/0000907254-26-000032.md) | [1,604](/filings/0000907254-26-000049.md) |
| Shareholders' equity | $m | [394](/filings/0000907254-23-000097.md) | [348](/filings/0000907254-25-000022.md) | [347](/filings/0000907254-24-000042.md) | [346](/filings/0000907254-24-000088.md) | [342](/filings/0000907254-24-000100.md) | [336](/filings/0000907254-26-000006.md) | [328](/filings/0000907254-25-000047.md) | [322](/filings/0000907254-25-000102.md) | [317](/filings/0000907254-25-000108.md) | [308](/filings/0000907254-26-000049.md) | [302](/filings/0000907254-26-000032.md) | [296](/filings/0000907254-26-000049.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.3 d](/filings/0000907254-24-000100.md) | [32.7 d](/filings/0000907254-26-000006.md) | [33.8](/filings/0000907254-25-000047.md) | [32.1 d](/filings/0000907254-25-000102.md) | [26.5 d](/filings/0000907254-25-000108.md) | [28.8 d](/filings/0000907254-26-000006.md) | [30.4](/filings/0000907254-26-000032.md) | [26.6 d](/filings/0000907254-26-000049.md) | [20.6 d](/filings/0000907254-25-000108.md) | [22.2 d](/filings/0000907254-26-000006.md) | [29.3](/filings/0000907254-26-000032.md) | [30.8 d](/filings/0000907254-26-000049.md) |
| Capital expenditure | $m | [47.9](/filings/0000907254-24-000100.md) | not reported | [45.6](/filings/0000907254-24-000042.md) | [44.6](/filings/0000907254-24-000088.md) | [54.8](/filings/0000907254-24-000100.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [14.2 d](/filings/0000907254-24-000100.md) | [14.2 d](/filings/0000907254-26-000006.md) | [14.2](/filings/0000907254-25-000047.md) | [14.2 d](/filings/0000907254-25-000102.md) | [14.2 d](/filings/0000907254-25-000108.md) | [14.3 d](/filings/0000907254-26-000006.md) | [14.3](/filings/0000907254-26-000032.md) | [14.3 d](/filings/0000907254-26-000049.md) | [14.3 d](/filings/0000907254-25-000108.md) | [14.3 d](/filings/0000907254-26-000006.md) | [14.3](/filings/0000907254-26-000032.md) | [14.5 d](/filings/0000907254-26-000049.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [24.0](/filings/0000907254-23-000097.md) | [24.0](/filings/0000907254-24-000042.md) | [24.0](/filings/0000907254-24-000088.md) | [24.1](/filings/0000907254-24-000100.md) | [24.1](/filings/0000907254-25-000047.md) | [24.1](/filings/0000907254-25-000102.md) | [24.2](/filings/0000907254-25-000108.md) | [24.2](/filings/0000907254-26-000032.md) | [24.2](/filings/0000907254-26-000049.md) | [24.2](/filings/0000907254-25-000108.md) | [24.4](/filings/0000907254-26-000032.md) | [24.4](/filings/0000907254-26-000049.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,717,101 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0000907254-26-000049.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.